485
Participants
Start Date
January 31, 2009
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
Aliskiren/amlodipine 300/10 mg tablet
Each dose was taken by mouth with water at approximately 8:00 in the morning with or without food, except on the morning of the next office/clinic visit, when the medication was taken at the site after the visit procedures were completed. In order to adequately blind the study, patients were required to take a total of two tablets and one capsule of study medication per day throughout the study.
Amlodipine 10 mg capsule
Each dose was taken by mouth with water at approximately 8:00 in the morning with or without food, except on the morning of the next office/clinic visit, when the medication was taken at the site after the visit procedures were completed. In order to adequately blind the study, patients were required to take a total of two tablets and one capsule of study medication per day throughout the study.
Investigative Site, Berlin
Investigative Site, Manila
Investigative Site, Bucharest
Investigative Site, Moscow
Investigative Site, Singapore
Investigative Site, Madrid
Lead Sponsor
Novartis
INDUSTRY